Comparison of clinical outcomes of Eyecryl toric and Alcon toric intra-ocular lenses - A real world study.


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
08 2023
Historique:
medline: 3 8 2023
pubmed: 2 8 2023
entrez: 2 8 2023
Statut: ppublish

Résumé

To compare the visual outcomes and residual astigmatism following implantation of Eyecryl toric versus Alcon AcrySof IQ toric intra-ocular lenses (IOLs). This retrospective, observational study included 143 eyes of 141 patients who underwent phaco-emulsification, followed by implantation of Eyecryl toric IOL (n = 83 eyes) or Alcon toric IOL (n = 60 eyes) in an eye hospital in South India from 2018 to 2021. At 1 month post-op, the uncorrected distance visual acuity (UCVA), best corrected distance visual acuity (BCVA), and residual astigmatism of the toric IOL were compared and analyzed. The mean pre-op corneal astigmatism was 2.02 ± 0.81 D and 1.70 ± 0.68 D in the Alcon and Eyecryl groups, respectively (P = 0.005). The mean post-op corneal astigmatism at 1 month was 0.50 ± 0.51 D and 0.36 ± 0.42 D in the Alcon and Eyecryl groups, respectively, with no statistically significant difference between them (P = 0.87). The mean post-op UCVA in logarithm of minimum angle of resolution (logMAR) at 1 month was similar between the groups at 0.17 ± 0.18 and 0.17 ± 0.16 in the Alcon and Eyecryl groups, respectively (P = 0.98). The mean post-op BCVA in logMAR at 1 month was 0.06 ± 0.09 and 0.03 ± 0.10 in the Alcon and Eyecryl groups, respectively (P = 0.02). Both Eyecryl toric and Alcon AcrySof IQ toric IOLs showed comparable post-operative outcomes in terms of UCVA and residual astigmatism. The post-op BCVA was clinically similar between groups but statistically better in the Eyecryl toric group.

Identifiants

pubmed: 37530267
pii: IndianJOphthalmol_2023_71_8_2972_382671
doi: 10.4103/IJO.IJO_3403_22
pmc: PMC10538847
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2972-2977

Déclaration de conflit d'intérêts

None

Références

J Cataract Refract Surg. 2012 Apr;38(4):730-1; author reply 731-2
pubmed: 22440449
Korean J Ophthalmol. 2019 Feb;33(1):36-45
pubmed: 30746910
Int Ophthalmol. 2017 Jun;37(3):683-689
pubmed: 27567924
J Ophthalmic Vis Res. 2014 Jul-Sep;9(3):324-8
pubmed: 25667733
Am J Ophthalmol. 2014 Feb;157(2):405-411.e1
pubmed: 24332372
Indian J Ophthalmol. 2017 Dec;65(12):1301-1313
pubmed: 29208810
J Cataract Refract Surg. 2013 Jan;39(1):41-47
pubmed: 23158681
J Cataract Refract Surg. 2010 Dec;36(12):2061-72
pubmed: 21111308
Indian J Ophthalmol. 2022 Jan;70(1):10-23
pubmed: 34937203
Ophthalmology. 2010 Nov;117(11):2104-11
pubmed: 20846724
Indian J Ophthalmol. 2021 Jul;69(7):1775-1780
pubmed: 34146027
Eye (Lond). 2019 Nov;33(11):1762-1767
pubmed: 31189992
Am J Ophthalmol. 2017 Aug;180:165-177
pubmed: 28647461
J Ophthalmol. 2016;2016:3257217
pubmed: 27022478
Exp Ther Med. 2020 Nov;20(5):25
pubmed: 32934690
J Cataract Refract Surg. 2012 Dec;38(12):2080-7
pubmed: 23069271
Br J Ophthalmol. 2016 Feb;100(2):258-62
pubmed: 26089214
Ophthalmology. 2016 Feb;123(2):275-286
pubmed: 26601819
J Cataract Refract Surg. 2011 Aug;37(8):1403-10
pubmed: 21782086
J Ophthalmol. 2018 Feb 11;2018:4064369
pubmed: 29607216
J Cataract Refract Surg. 2015 May;41(5):936-44
pubmed: 25936681
Indian J Ophthalmol. 2022 Mar;70(3):801-806
pubmed: 35225518
Case Rep Ophthalmol. 2013 Jun 27;4(2):48-56
pubmed: 23898293
Ophthalmology. 2000 Sep;107(9):1776-81; discussion 1781-2
pubmed: 10964844
Indian J Ophthalmol. 2020 Dec;68(12):3016-3019
pubmed: 33229689
J Cataract Refract Surg. 2014 Oct;40(10):1654-60
pubmed: 25149554
Int Ophthalmol. 2021 Nov;41(11):3769-3780
pubmed: 34292480
BMC Ophthalmol. 2018 Nov 9;18(1):292
pubmed: 30413154
J Cataract Refract Surg. 2010 Sep;36(9):1479-85
pubmed: 20692558
Ophthalmology. 2015 Jan;122(1):39-47
pubmed: 25444352
Can J Ophthalmol. 2009 Jun;44(3):269-73
pubmed: 19491980
J Cataract Refract Surg. 2011 Feb;37(2):235-40
pubmed: 21241904
J Refract Surg. 2012 Oct;28(10):729-32
pubmed: 22978297
Cornea. 2005 Jul;24(5):509-22
pubmed: 15968154
Indian J Ophthalmol. 2018 Oct;66(10):1423-1428
pubmed: 30249826
Arch Ophthalmol. 2011 Aug;129(8):998-1003
pubmed: 21825183
J Cataract Refract Surg. 2009 Jan;35(1):70-5
pubmed: 19101427
J Cataract Refract Surg. 2021 May 1;47(5):622-626
pubmed: 33181626
J Refract Surg. 2012 Aug;28(8):551-5
pubmed: 22785061
Curr Opin Ophthalmol. 2007 Feb;18(1):58-61
pubmed: 17159449
Acta Ophthalmol. 2017 Mar;95(2):e95-e100
pubmed: 27573881
J Cataract Refract Surg. 1994 Sep;20(5):523-6
pubmed: 7996408
J Cataract Refract Surg. 2021 Feb 1;47(2):178-183
pubmed: 32925653
J Cataract Refract Surg. 2012 Apr;38(4):648-54
pubmed: 22342010

Auteurs

Nilay Reddy Korpole (NR)

Department of Ophthalmology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Padma Kurada (P)

Drishti Eye Centre, Plot No. 114A, Lane Opp. SBI, Srinagar Colony Main Road, Ameerpet, Hyderabad, India.

Neetha I R Kuzhuppilly (NIR)

Department of Ophthalmology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Madhukar Reddy Korpole (MR)

Drishti Eye Centre, Plot No. 114A, Lane Opp. SBI, Srinagar Colony Main Road, Ameerpet, Hyderabad, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH